Li S N, Lai J M, Kang M, Yue T, Wang X L
Department of Rheumatology, Children's Hospital, Capital Institute of Pediatrics, Beijing 100020, China.
Zhonghua Er Ke Za Zhi. 2022 May 2;60(5):462-465. doi: 10.3760/cma.j.cn112140-20210923-00818.
To investigate the clinical characteristics of systemic juvenile idiopathic arthritis combined with coronary artery dilatation. A retrospective analysis was performed on the clinical data, including clinical manifestations, blood routine, inflammatory factors, echocardiography, vascular ultrasound and CT angiography, treatment and outcomes, etc, of 5 cases with systemic juvenile idiopathic arthritis combined with coronary artery dilation admitted to Department of Rheumatology in the affiliated Children's Hospital of Capital Institute of Pediatrics from May 2019 to June 2021. There were 2 males and 3 females among 5 cases. The onset age ranged from 7 months to 4 years 7 months.The diagnostic time ranged from 1.5 months to 3.0 months.Four cases were diagnosed as atypical Kawasaki disease. Three cases showed unilateral coronary artery dilation.Two cases showed bilateral coronary artery dilation.Four cases developed multiple organ injuries.Three cases developed macrophage activation syndrome.Three cases developed lung injury.Two cases developed pericardial effusion.One case developed pulmonary hypertension.As for treatment, 3 cases treated with methylprednisolone pulse therapy and methotrexate combined with cyclosporine, improved after the final application of biological agents, and have stopped prednisone. The other 2 cases were treated with adequate oral prednisone and gradually reduced, and methotrexate was added at the same time, 1 case relapsed in the process of reduction. No other vascular involvement was found in 5 cases. Coronary artery dilation recovered completely after 1 to 3 months of treatment. Systemic juvenile idiopathic arthritis combined with coronary artery dilatation has the clinical characteristics of small onset age, long diagnostic time, prone to multiple organ injuries. Corticosteroids and conventional immunosuppressive agents are not sensitive, and biological agents should be used as soon as possible.The prognosis of coronary artery dilation is good after timely treatment.
探讨全身型幼年特发性关节炎合并冠状动脉扩张的临床特点。对2019年5月至2021年6月首都儿科研究所附属儿童医院风湿免疫科收治的5例全身型幼年特发性关节炎合并冠状动脉扩张患儿的临床表现、血常规、炎症因子、超声心动图、血管超声及CT血管造影、治疗及转归等临床资料进行回顾性分析。5例患儿中男2例,女3例。发病年龄7个月至4岁7个月。确诊时间1.5个月至3.0个月。4例诊断为非典型川崎病。3例表现为单侧冠状动脉扩张,2例表现为双侧冠状动脉扩张。4例出现多脏器损伤,3例发生巨噬细胞活化综合征,3例出现肺损伤,2例出现心包积液,1例出现肺动脉高压。治疗方面,3例采用甲泼尼龙冲击治疗及甲氨蝶呤联合环孢素治疗,最终应用生物制剂后病情改善,已停用泼尼松。另2例予足量口服泼尼松并逐渐减量,同时加用甲氨蝶呤,1例在减量过程中复发。5例均未发现其他血管受累。治疗1至3个月后冠状动脉扩张完全恢复。全身型幼年特发性关节炎合并冠状动脉扩张具有发病年龄小、确诊时间长、易出现多脏器损伤等临床特点。糖皮质激素及传统免疫抑制剂不敏感,应尽早使用生物制剂。及时治疗后冠状动脉扩张预后良好。